Effects of beta-amyloid protein on M1 and M2 subtypes of muscarinic acetylcholine receptors in the medial septum-diagonal band complex of the rat: relationship with cholinergic, GABAergic, and calcium-binding protein perikarya.
Cortical cholinergic dysfunction has been correlated with the expression and processing of beta-amyloid precursor protein. However, it remains unclear as to how cholinergic dysfunction and beta-amyloid (Abeta) formation and deposition might be related to one another. Since the M1- and M2 subtypes of muscarinic acetylcholine receptors (mAChRs) are considered key molecules that transduce the cholinergic message, the purpose of the present study was to assess the effects of the injected Abeta peptide on the number of M1mAchR- and M2mAChR-immunoreactive cells in the medial septum-diagonal band (MS-nDBB) complex of the rat. Injections of Abeta protein into the retrosplenial cortex resulted in a decrease in M1mAChR and M2mAChR immunoreactivity in the MS-nDBB complex. Quantitative analysis revealed a significant reduction in the number of M1mAChR- and M2mAChR-immunoreactive cells in the medial septum nucleus (MS) and in the horizontal nucleus of the diagonal band of Broca (HDB) as compared to the corresponding hemisphere in control animals and with that seen in the contralateral hemisphere, which corresponds to the PBS-injected side. Co-localization studies showed that the M1mAChR protein is localized in GABA-immunoreactive cells of the MS-nDBB complex, in particular those of the MS nucleus, while M2mAChR protein is localized in both the cholinergic and GABAergic cells. Moreover, GABAergic cells containing M2mAChR are mainly localized in the MS nucleus, while cholinergic cells containing M2mAChR are localized in the MS and the HDB nuclei. Our findings suggest that Abeta induces a reduction in M1mAChR- and M2mAChR-containing cells, which may contribute to impairments of cholinergic and GABAergic transmission in the MS-nDBB complex.
González
Iván
I
Laboratory of Neuroanatomy, Institute of Neuroscience of Castilla and León, University of Valladolid, Campus de los Pajaritos de Soria, 42004 Soria, Spain.
Arévalo-Serrano
Juan
J
Sanz-Anquela
José Miguel
JM
Gonzalo-Ruiz
Alicia
A
D016229:Amyloid beta-Peptides / Q000302:isolation & purification / Q000494:pharmacology*; D000818:Animals; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002452:Cell Count; D020667:Diagonal Band of Broca / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D007150:Immunohistochemistry; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000502:physiology*; D010446:Peptide Fragments / Q000302:isolation & purification / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D043643:Receptor, Muscarinic M1 / Q000187:drug effects*; D043585:Receptor, Muscarinic M2 / Q000187:drug effects*; D020665:Septum of Brain / Q000187:drug effects / Q000378:metabolism*; D016707:Tissue Fixation; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D016229:Amyloid beta-Peptides; D002135:Calcium-Binding Proteins; D010446:Peptide Fragments; D043643:Receptor, Muscarinic M1; D043585:Receptor, Muscarinic M2; C078592:amyloid beta-protein (1-40); D005680:gamma-Aminobutyric Acid